{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:07:59Z","timestamp":1791295679170,"version":"4.1.0"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Current immunodiagnostic tests for tuberculosis (TB), including the tuberculin skin test and IFN-\u03b3 release assay (IGRA), have significant limitations, which include their inability to distinguish between latent TB infection (LTBI) and active TB, a distinction critical for clinical management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To identify mycobacteria-specific cytokine biomarkers that characterize TB infection, determine their diagnostic performance characteristics, and establish whether these biomarkers can distinguish between LTBI and active TB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 149 children investigated for TB infection were recruited; all participants underwent a tuberculin skin test and QuantiFERON-TB Gold assay. In parallel, whole-blood assays using early secretory antigenic target-6, culture filtrate protein-10, and PPD as stimulatory antigens were undertaken, and cytokine responses were determined by xMAP multiplex assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>IFN-\u03b3, interferon-inducible protein-10 (IP-10), tumor necrosis factor (TNF)-\u03b1, IL-1ra, IL-2, IL-13, and MIP-1\u03b2 (macrophage inflammatory protein-1\u03b2) responses were significantly higher in LTBI and active TB cases than in TB-uninfected individuals, irrespective of the stimulant. Receiver operating characteristic analyses showed that IP-10, TNF-\u03b1, and IL-2 responses achieved high sensitivity and specificity for the distinction between TB-uninfected and TB-infected individuals. TNF-\u03b1, IL-1ra, and IL-10 responses had the greatest ability to distinguish between LTBI and active TB cases; the combinations of TNF-\u03b1\/IL-1ra and TNF-\u03b1\/IL-10 achieved correct classification of 95.5% and 100% of cases, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We identified several mycobacteria-specific cytokine biomarkers with the potential to be exploited for immunodiagnosis. Incorporation of these biomarkers into future immunodiagnostic assays for TB could result in substantial gains in sensitivity and allow the distinction between LTBI and active TB based on a blood test alone.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201501-0059oc","type":"journal-article","created":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T18:13:35Z","timestamp":1433182415000},"page":"485-499","source":"Crossref","is-referenced-by-count":107,"title":["Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis"],"prefix":"10.1093","volume":"192","author":[{"given":"Marc","family":"Tebruegge","sequence":"first","affiliation":[{"name":"Department of Paediatrics and"},{"name":"Infectious Diseases Unit and"},{"name":"Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"},{"name":"Academic Unit of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binita","family":"Dutta","sequence":"additional","affiliation":[{"name":"Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Donath","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and"},{"name":"Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"},{"name":"Clinical Epidemiology and Biostatistics Unit, Royal Children\u2019s Hospital Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Ritz","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and"},{"name":"Infectious Diseases Unit and"},{"name":"Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"},{"name":"Infectious Diseases Unit, University Children\u2019s Hospital Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Forbes","sequence":"additional","affiliation":[{"name":"Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kattia","family":"Camacho-Badilla","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Clifford","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and"},{"name":"Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Zufferey","sequence":"additional","affiliation":[{"name":"Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Robins-Browne","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and"},{"name":"Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"},{"name":"Department of Microbiology and Immunology, The University of Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"Hanekom","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Graham","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and"},{"name":"Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"},{"name":"Centre for International Child Health, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Connell","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and"},{"name":"Infectious Diseases Unit and"},{"name":"Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and"},{"name":"Infectious Diseases Unit and"},{"name":"Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,8,15]]},"reference":[{"key":"2026032100165760600_bib1","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(06)68384-0","article-title":"Global epidemiology of tuberculosis","volume":"367","author":"Dye","year":"2006","journal-title":"Lancet"},{"key":"2026032100165760600_bib2","author":"World Health Organization"},{"key":"2026032100165760600_bib3","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1164\/rccm.200511-1809SO","article-title":"Childhood pulmonary tuberculosis: old wisdom and new challenges","volume":"173","author":"Marais","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100165760600_bib4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(11)70167-0","article-title":"Accuracy of the Xpert MTB\/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study","volume":"11","author":"Nicol","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"2026032100165760600_bib5","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1056\/NEJMc1210173","article-title":"Tuberculosis in children","volume":"367","author":"Tebruegge","year":"2012","journal-title":"N Engl J Med"},{"key":"2026032100165760600_bib6","article-title":"Diagnostic tests for childhood tuberculosis \u2013 past imperfect, present tense and future perfect?","author":"Tebruegge","journal-title":"Pediatr Infect Dis J"},{"key":"2026032100165760600_bib7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1183\/09031936.00025510","article-title":"Discordance between TSTs and IFN-gamma release assays: the role of NTM and the relevance of mycobacterial sensitins","volume":"36","author":"Tebruegge","year":"2010","journal-title":"Eur Respir J"},{"key":"2026032100165760600_bib8","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","article-title":"Specific immune-based diagnosis of tuberculosis","volume":"356","author":"Andersen","year":"2000","journal-title":"Lancet"},{"key":"2026032100165760600_bib9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1183\/09031936.00114810","article-title":"Interferon-\u03b3 release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis","volume":"37","author":"Sester","year":"2011","journal-title":"Eur Respir J"},{"key":"2026032100165760600_bib10","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/INF.0b013e3181b00dbf","article-title":"Interferon-gamma release assays for the diagnosis of tuberculosis","volume":"28","author":"Connell","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"2026032100165760600_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/thx.2010.143396","article-title":"The potential danger of a solely interferon-gamma release assay-based approach to testing for latent Mycobacterium tuberculosis infection in children","volume":"66","author":"Connell","year":"2011","journal-title":"Thorax"},{"key":"2026032100165760600_bib12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/INF.0b013e3181c4822f","article-title":"Indeterminate interferon-gamma release assay results in children","volume":"29","author":"Connell","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"2026032100165760600_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/INF.0b013e3181a16394","article-title":"The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status","volume":"28","author":"Haustein","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"2026032100165760600_bib14","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1128\/JCM.00814-14","article-title":"Extremes of age are associated with indeterminate QuantiFERON-TB gold assay results","volume":"52","author":"Tebruegge","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2026032100165760600_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/35095558","article-title":"How can immunology contribute to the control of tuberculosis?","volume":"1","author":"Kaufmann","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"2026032100165760600_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1586\/ers.09.31","article-title":"Biomarkers of latent TB infection","volume":"3","author":"Ruhwald","year":"2009","journal-title":"Expert Rev Respir Med"},{"key":"2026032100165760600_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tube.2015.01.003","article-title":"Cytokine biomarkers for monitoring anti-tuberculous therapy: a systematic review","volume":"95","author":"Clifford","year":"2015","journal-title":"Tuberculosis (Edinb)"},{"key":"2026032100165760600_bib18","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1183\/09031936.00017807","article-title":"Evidence for boosting Mycobacterium tuberculosis-specific IFN-gamma responses at 6 weeks following tuberculin skin testing","volume":"29","author":"Naseer","year":"2007","journal-title":"Eur Respir J"},{"key":"2026032100165760600_bib19","doi-asserted-by":"crossref","first-page":"767","DOI":"10.5588\/ijtld.10.0339","article-title":"Absence of interferon-gamma release assay conversion following tuberculin skin testing","volume":"15","author":"Ritz","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026032100165760600_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-90-481-9039-3_18","article-title":"Mycobacterium tuberculosis complex","volume-title":"PCR for clinical microbiology, 1st ed","author":"Globan","year":"2010"},{"key":"2026032100165760600_bib21","first-page":"1376","article-title":"Diagnostic standards and classification of tuberculosis in adults and children. Official statement of the American Thoracic Society and the Centers for Disease Control and Prevention","volume":"161","author":"American Thoracic Society and the Centers for Disease Control and Prevention","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100165760600_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-3-25","article-title":"The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews","volume":"3","author":"Whiting","year":"2003","journal-title":"BMC Med Res Methodol"},{"key":"2026032100165760600_bib23","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nm.2299","article-title":"Dominant TNF-\u03b1+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease","volume":"17","author":"Harari","year":"2011","journal-title":"Nat Med"},{"key":"2026032100165760600_bib24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/00365548.2011.632644","article-title":"Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study","volume":"44","author":"Alsleben","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"2026032100165760600_bib25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jinf.2013.08.005","article-title":"Cytokine responses to quantiferon peptides in pediatric tuberculosis: a pilot study","volume":"68","author":"Armand","year":"2014","journal-title":"J Infect"},{"key":"2026032100165760600_bib26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tube.2011.02.006","article-title":"Discriminating between latent and active tuberculosis with multiple biomarker responses","volume":"91","author":"Frahm","year":"2011","journal-title":"Tuberculosis (Edinb)"},{"key":"2026032100165760600_bib27","doi-asserted-by":"crossref","first-page":"e3901","DOI":"10.1371\/journal.pone.0003901","article-title":"Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma?","volume":"3","author":"Whittaker","year":"2008","journal-title":"PLoS One"},{"key":"2026032100165760600_bib28","doi-asserted-by":"crossref","first-page":"e23733","DOI":"10.1371\/journal.pone.0023733","article-title":"Can interferon-gamma or interferon-gamma-induced-protein-10 differentiate tuberculosis infection and disease in children of high endemic areas?","volume":"6","author":"Yassin","year":"2011","journal-title":"PLoS One"},{"key":"2026032100165760600_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1756-0500-2-19","article-title":"IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay","volume":"2","author":"Ruhwald","year":"2009","journal-title":"BMC Res Notes"},{"key":"2026032100165760600_bib30","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.micinf.2007.02.021","article-title":"CXCL10\/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7","volume":"9","author":"Ruhwald","year":"2007","journal-title":"Microbes Infect"},{"key":"2026032100165760600_bib31","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.4049\/jimmunol.162.8.4928","article-title":"Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils","volume":"162","author":"Gasperini","year":"1999","journal-title":"J Immunol"},{"key":"2026032100165760600_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1128\/iai.45.1.25-28.1984","article-title":"In vivo and in vitro administration of interleukin 2-containing preparation reverses T-cell unresponsiveness in Mycobacterium bovis BCG-infected mice","volume":"45","author":"Colizzi","year":"1984","journal-title":"Infect Immun"},{"key":"2026032100165760600_bib33","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/iai.59.2.570-574.1991","article-title":"Immunomodulation of mouse macrophage killing of Mycobacterium avium in vitro","volume":"59","author":"Hubbard","year":"1991","journal-title":"Infect Immun"},{"key":"2026032100165760600_bib34","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1469-0691.2009.03104.x","article-title":"Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls","volume":"16","author":"Biselli","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"2026032100165760600_bib35","doi-asserted-by":"crossref","first-page":"e15619","DOI":"10.1371\/journal.pone.0015619","article-title":"Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis","volume":"5","author":"Casey","year":"2010","journal-title":"PLoS One"},{"key":"2026032100165760600_bib36","doi-asserted-by":"crossref","first-page":"e46041","DOI":"10.1371\/journal.pone.0046041","article-title":"Potential role of M. tuberculosis specific IFN-\u03b3 and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis","volume":"7","author":"Chiappini","year":"2012","journal-title":"PLoS One"},{"key":"2026032100165760600_bib37","doi-asserted-by":"crossref","first-page":"e11670","DOI":"10.1371\/journal.pone.0011670","article-title":"Potential role for IL-2 ELISpot in differentiating recent and remote infection in tuberculosis contact tracing","volume":"5","author":"Krummel","year":"2010","journal-title":"PLoS One"},{"key":"2026032100165760600_bib38","first-page":"1548","article-title":"Cytokine responses to QuantiFERON\u00ae peptides, purified protein derivative and recombinant ESAT-6 in children with tuberculosis","volume":"14","author":"Lighter-Fisher","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026032100165760600_bib39","doi-asserted-by":"crossref","first-page":"e51338","DOI":"10.1371\/journal.pone.0051338","article-title":"Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"2026032100165760600_bib40","doi-asserted-by":"crossref","first-page":"e64226","DOI":"10.1371\/journal.pone.0064226","article-title":"Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting","volume":"8","author":"Chegou","year":"2013","journal-title":"PLoS One"},{"key":"2026032100165760600_bib41","doi-asserted-by":"crossref","first-page":"e44944","DOI":"10.1371\/journal.pone.0044944","article-title":"Different patterns of cytokines and chemokines combined with IFN-\u03b3 production reflect Mycobacterium tuberculosis infection and disease","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS One"},{"key":"2026032100165760600_bib42","doi-asserted-by":"crossref","first-page":"e12365","DOI":"10.1371\/journal.pone.0012365","article-title":"Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort","volume":"5","author":"Sutherland","year":"2010","journal-title":"PLoS One"},{"key":"2026032100165760600_bib43","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?","volume":"10","author":"Farhat","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026032100165760600_bib44","doi-asserted-by":"crossref","first-page":"e2624","DOI":"10.1371\/journal.pone.0002624","article-title":"A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children","volume":"3","author":"Connell","year":"2008","journal-title":"PLoS One"},{"key":"2026032100165760600_bib45","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/thx.2005.048033","article-title":"Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children","volume":"61","author":"Connell","year":"2006","journal-title":"Thorax"},{"key":"2026032100165760600_bib46","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1542\/peds.2005-2095","article-title":"Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis","volume":"117","author":"Hill","year":"2006","journal-title":"Pediatrics"},{"key":"2026032100165760600_bib47","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/QCO.0b013e32832dda55","article-title":"Infectious complications of tumor necrosis factor blockade","volume":"22","author":"Wallis","year":"2009","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"2026032100165760600_bib48","first-page":"CD008794","article-title":"Adverse effects of biologics: a network meta-analysis and Cochrane overview","author":"Singh","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2026032100165760600_bib49","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.4049\/jimmunol.156.7.2503","article-title":"IL-1 receptor antagonist (IL-1ra) expression, function, and cytokine-mediated regulation during mycobacterial and schistosomal antigen-elicited granuloma formation","volume":"156","author":"Ruth","year":"1996","journal-title":"J Immunol"},{"key":"2026032100165760600_bib50","doi-asserted-by":"crossref","first-page":"e10469","DOI":"10.1371\/journal.pone.0010469","article-title":"In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of Gr-1 cells in the lungs","volume":"5","author":"Lyadova","year":"2010","journal-title":"PLoS One"},{"key":"2026032100165760600_bib51","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1128\/IAI.70.4.1684-1693.2002","article-title":"Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth","volume":"70","author":"Saukkonen","year":"2002","journal-title":"Infect Immun"},{"key":"2026032100165760600_bib52","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/002215549904700107","article-title":"Cytoskeletal and adhesive structural polarizations accompany IL-13-induced human macrophage fusion","volume":"47","author":"DeFife","year":"1999","journal-title":"J Histochem Cytochem"},{"key":"2026032100165760600_bib53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat Rev Immunol"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/192\/4\/485\/67214048\/ajrccm_192_4_485.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/192\/4\/485\/67214048\/ajrccm_192_4_485.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:17:09Z","timestamp":1774066629000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/192\/4\/485\/8504692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,8,15]]},"published-print":{"date-parts":[[2015,8,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201501-0059oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,8]]},"published":{"date-parts":[[2015,8]]}}}